Publication | Closed Access
Effects of follow-on therapy after denosumab discontinuation in patients with postmenopausal osteoporosis
27
Citations
19
References
2020
Year
These results may contribute to the selection of adequate follow-on therapy after DMAb discontinuation, although further investigations are required.
| Year | Citations | |
|---|---|---|
Page 1
Page 1